MedPath

Review of the Paediatric Pleuropulmonary Blastoma French Series

Completed
Conditions
Pleuropulmonary Blastoma
Interventions
Other: PPB
Registration Number
NCT03044834
Lead Sponsor
Rennes University Hospital
Brief Summary

Pleuropulmonary blastoma is a rare embryonic malignant tumour that remains the most frequent malignant tumour of the lung in childhood. The International Pleuro pulmonary Blastoma Registry (IPPB) found only 220 cases in 2009 and 350 in 2015. In France, 20 cases were identified in 2009.

Three histologies are described: type 1 purely cystic, type 2 combined and type 3 solid. Median age at diagnostic is 12 months, 35 months and 41 months respectively. Evolution is possible from type 1 to type 2 or 3 in 10% of the cases.

Since 2009, DICER 1 mutations research is proposed systematically to all families.

PPB symptoms are usually non-specific. Diagnostic is evoked when imaging work up shows bubbles or solid lesions, and confirmed by pathological analysis. However the diagnosis can be difficult because of the proximity with congenital cystic adenomatoid malformation.

The French society of paediatric oncology recommends surgery at first instance. PPB type 1 remains a problem because some are still misdiagnosed as CCAM, a benign lesion. Chemotherapy depends on the PPB type and the quality of the resection. There is a real interest to analyse the French series.

The prognosis of type 2 and 3 is low with a 5 years survival rate of 45-60%, whereas type 1 survival rate is 91%. The French experience reports a 100% survival rate in type 1 and 48% in type 2 and 3. Other prognostic factors are initial size of the tumour, extra pulmonary invasion and quality of surgery.

Early local relapses are possible and late ones concern more often type 2 and 3 with more cerebral metastasis.

In 2009, the french cases were collected, but no update has been performed since. The aim of this retrospective review of the cases since 2000, is to audit the care of PPB patients in France and update the French rare tumour database.

Evoking PPB diagnosis is difficult when imaging shows a neonatal cystic lesion. There are no radiologic criteria in the literature that differentiate congenital pulmonary cystic lesion and PPB type 1. Radiological presentation is however overlapping. Another aim of this study will be to look for a predictive sign of type 1 PPB.

Detailed Description

Multicentre retrospective study

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • Patients born between 01/01/2000 and 01/01/2016 ;
  • Followed up for PPB
  • Treated in a French department of paediatric oncology or paediatric surgery
  • Study agreement
Exclusion Criteria
  • Part of the care out of France
  • Study disagreement

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pleuropulmonary BlastomaPPB* Patients born between 01/01/2000 and 01/01/2016 ; * Followed up for PPB * Treated in a French department of paediatric oncology or paediatric surgery * Study agreement
Primary Outcome Measures
NameTimeMethod
Overall survivalWithin 5 years from the diagnosis
Progression free survivalWithin 5 years from the diagnosis

Characterize the evolution and the global care of PPB in the French series

Secondary Outcome Measures
NameTimeMethod
Radiology signWithin 5 years from the diagnosis

Identification of a type 1 PPB predictive radiological sign

State of PPB surgical careWithin 5 years from the diagnosis

Trial Locations

Locations (18)

Angers University Hospital

πŸ‡«πŸ‡·

Angers, France

Curie Institute

πŸ‡«πŸ‡·

Saint-Cloud, France

Toulouse University Hospital

πŸ‡«πŸ‡·

Toulouse, France

RΓ©union University Hospital

πŸ‡«πŸ‡·

Saint-Paul, France

Grenoble University Hospital

πŸ‡«πŸ‡·

Grenoble, France

Tours University Hospital

πŸ‡«πŸ‡·

Tours, France

Bordeaux University Hospital

πŸ‡«πŸ‡·

Bordeaux, France

Gustave Roussy Institute

πŸ‡«πŸ‡·

Villejuif, France

Nice University Hospital

πŸ‡«πŸ‡·

Nice, France

Poitiers University Hospital

πŸ‡«πŸ‡·

Poitiers, France

Caen University Hospital

πŸ‡«πŸ‡·

Caen, France

Kremlin-BicΓͺtre Hospital

πŸ‡«πŸ‡·

Le Kremlin-BicΓͺtre, France

Lille University Hospital

πŸ‡«πŸ‡·

Lille, France

Nantes University Hospital

πŸ‡«πŸ‡·

Nantes, France

Necher Hospital

πŸ‡«πŸ‡·

Paris, France

Montpellier University Hospital

πŸ‡«πŸ‡·

Montpellier, France

Lyon Universty Hospital

πŸ‡«πŸ‡·

Lyon, France

Marseille University Hospital

πŸ‡«πŸ‡·

Marseille, France

Β© Copyright 2025. All Rights Reserved by MedPath